Phidelta Pharma SRL
1.6 FTEPhidelta Pharma reported total assets of 216,336 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Sep 2026), with 1.6 full-time equivalent.
The score of Phidelta Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets -3 % Headcount (avg FTE) +60 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phidelta Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Sep 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 25 Apr 2022
Phidelta Pharma's financial analysis
- Solvency24.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phidelta Pharma
Phidelta Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0694.733.893
- VAT number
- BE0694733893
- Peppol
- Registered · 0208:0694733893 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Apr 2018
- Registered office
- 4000 Liège
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 28 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phidelta Pharma (SRL) has been based in Liège since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 38 € and equity of 53,943 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Phidelta Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek J. DRAULANS Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 215,560 €
- Pharmacie van Elewyck Retail sale of pharmaceutical products Saint-Gilles · balance sheet 215,446 €
- Pharmasolutions Retail sale of pharmaceutical products Linkebeek · balance sheet 215,436 €
- MDB Pharma Retail sale of pharmaceutical products Ghent · balance sheet 214,811 €
- Obiphar Retail sale of pharmaceutical products Frameries · balance sheet 218,848 €
- Le Lumeçon Retail sale of pharmaceutical products Brussels · balance sheet 213,394 €
- Castoro Retail sale of pharmaceutical products Pajottegem · balance sheet 213,183 €
- Apoteek't Groen Kruis Retail sale of pharmaceutical products Schoten · balance sheet 220,163 €
Frequently asked questions about Phidelta Pharma
What is the revenue of Phidelta Pharma?
Phidelta Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phidelta Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0694733893 for Phidelta Pharma, if the company is VAT-registered. Its company number (CBE) is 0694.733.893.
Where is the registered office of Phidelta Pharma?
According to the CBE register, the registered office of Phidelta Pharma is in 4000 Liège.
What is the equity of Phidelta Pharma?
At the close of the 2025 financial year, the equity of Phidelta Pharma amounts to 53,943 €, a solvency of 24.9% of total assets.
How many people work at Phidelta Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phidelta Pharma?
The register lists 1 active mandates at Phidelta Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phidelta Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →